Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound
US11564924B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 22, 2020 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Dec 24, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vitamin B1 deficiency caused when a pyridoxamine compound is administered in a large amount is prevented and/or treated. A pharmaceutical composition formed by combining at least one pyridoxamine compound selected from the group consisting of pyridoxamine and pharmaceutically acceptable salts thereof and at least one thiamine compound selected from the group consisting of thiamine, derivatives thereof, and pharmaceutically acceptable salts thereof, is administered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.